Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach

The purpose of the study was to investigate the safety and efficacy of transradial artery approach (TRA) in STEMI patients who reperfused early (≤3 h from symptoms onset) or late (>3 h from symptoms onset) by either PPCI or pharmaco-invasive strategy (PI), thrombolysis followed by CA. Therefore,...

Full description

Bibliographic Details
Main Authors: El-Zahraa M. Sultan, Hoda M. Rabea, Khaled R. abdelmeguid, Hesham B. Mahmoud
Format: Article
Language:English
Published: SpringerOpen 2018-03-01
Series:The Egyptian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1110260816301624
_version_ 1818324012319637504
author El-Zahraa M. Sultan
Hoda M. Rabea
Khaled R. abdelmeguid
Hesham B. Mahmoud
author_facet El-Zahraa M. Sultan
Hoda M. Rabea
Khaled R. abdelmeguid
Hesham B. Mahmoud
author_sort El-Zahraa M. Sultan
collection DOAJ
description The purpose of the study was to investigate the safety and efficacy of transradial artery approach (TRA) in STEMI patients who reperfused early (≤3 h from symptoms onset) or late (>3 h from symptoms onset) by either PPCI or pharmaco-invasive strategy (PI), thrombolysis followed by CA. Therefore, a total 143 STEMI patients (who were presented within 12 h from symptoms onset or 12–24 h with an evidence of ongoing ischemia or suffered from an acute STEMI were randomized for either PI or PPCI. Eighty-two patients were assigned to PI arm while the rest assigned were to PPCI arm. Patients who were taken to a non-PCI capable hospital received streptokinase and were then transferred to our Hospital for CA. TRA was used in the catheterization laboratory for all patients. Each arm was divided according to reperfusion time into early and late subgroups. A primary endpoint was death, shock, congestive heart failure, or reinfarction up to 30 days. There was a non-significant difference regarding LVEF in both arms. Myocardium wall preservation was significant in the early PI arm (P = 0.023). TIMI flow had no discrepancy between both arms (P = 0.569). Mean procedural and fluoroscopic time were 35.1 ± 6.1 and 6.3 ± 0.9 min. There were no reported entry site complications. There was no difference in primary endpoint complications (P = 0.326) considering the different times of patients’ reperfusion (early; P = 0.696 vs. late; P = 0.424). In conclusion, it is safe and effective to use TRA in STEMI patients who reperfused by either early or late PPCI or PI. We recommend PI for STEMI patients with delay presentation if PPCI is not available. Keywords: ST-myocardial infarction, Primary PCI, Pharmaco-invasive, Transradial approach, Streptokinase
first_indexed 2024-12-13T11:21:49Z
format Article
id doaj.art-7163723a9373451ca6746533de9637e3
institution Directory Open Access Journal
issn 1110-2608
language English
last_indexed 2024-12-13T11:21:49Z
publishDate 2018-03-01
publisher SpringerOpen
record_format Article
series The Egyptian Heart Journal
spelling doaj.art-7163723a9373451ca6746533de9637e32022-12-21T23:48:27ZengSpringerOpenThe Egyptian Heart Journal1110-26082018-03-0170117Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approachEl-Zahraa M. Sultan0Hoda M. Rabea1Khaled R. abdelmeguid2Hesham B. Mahmoud3Clinical Pharmacist, Cardiovascular Department, Beni-Suef Hospital University, Egypt; Corresponding author.Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, EgyptLecturer of Cardiology, Beni-Suef Hospital University, Beni-Suef, EgyptProf. of Cardiology, Beni-Suef Hospital University, Beni-Suef, EgyptThe purpose of the study was to investigate the safety and efficacy of transradial artery approach (TRA) in STEMI patients who reperfused early (≤3 h from symptoms onset) or late (>3 h from symptoms onset) by either PPCI or pharmaco-invasive strategy (PI), thrombolysis followed by CA. Therefore, a total 143 STEMI patients (who were presented within 12 h from symptoms onset or 12–24 h with an evidence of ongoing ischemia or suffered from an acute STEMI were randomized for either PI or PPCI. Eighty-two patients were assigned to PI arm while the rest assigned were to PPCI arm. Patients who were taken to a non-PCI capable hospital received streptokinase and were then transferred to our Hospital for CA. TRA was used in the catheterization laboratory for all patients. Each arm was divided according to reperfusion time into early and late subgroups. A primary endpoint was death, shock, congestive heart failure, or reinfarction up to 30 days. There was a non-significant difference regarding LVEF in both arms. Myocardium wall preservation was significant in the early PI arm (P = 0.023). TIMI flow had no discrepancy between both arms (P = 0.569). Mean procedural and fluoroscopic time were 35.1 ± 6.1 and 6.3 ± 0.9 min. There were no reported entry site complications. There was no difference in primary endpoint complications (P = 0.326) considering the different times of patients’ reperfusion (early; P = 0.696 vs. late; P = 0.424). In conclusion, it is safe and effective to use TRA in STEMI patients who reperfused by either early or late PPCI or PI. We recommend PI for STEMI patients with delay presentation if PPCI is not available. Keywords: ST-myocardial infarction, Primary PCI, Pharmaco-invasive, Transradial approach, Streptokinasehttp://www.sciencedirect.com/science/article/pii/S1110260816301624
spellingShingle El-Zahraa M. Sultan
Hoda M. Rabea
Khaled R. abdelmeguid
Hesham B. Mahmoud
Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach
The Egyptian Heart Journal
title Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach
title_full Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach
title_fullStr Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach
title_full_unstemmed Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach
title_short Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach
title_sort transradial artery approach in stemi patients reperfused early and late by either primary pci or pharmaco invasive approach
url http://www.sciencedirect.com/science/article/pii/S1110260816301624
work_keys_str_mv AT elzahraamsultan transradialarteryapproachinstemipatientsreperfusedearlyandlatebyeitherprimarypciorpharmacoinvasiveapproach
AT hodamrabea transradialarteryapproachinstemipatientsreperfusedearlyandlatebyeitherprimarypciorpharmacoinvasiveapproach
AT khaledrabdelmeguid transradialarteryapproachinstemipatientsreperfusedearlyandlatebyeitherprimarypciorpharmacoinvasiveapproach
AT heshambmahmoud transradialarteryapproachinstemipatientsreperfusedearlyandlatebyeitherprimarypciorpharmacoinvasiveapproach